Terms: = Uterine cancer AND DDX5, HLR1, 1655, ENSG00000108654, P17844, DKFZp686J01190, p68, G17P1, HUMP68
13 results:
1. Invasive stratified mucin-producing carcinoma (ISMC) of the cervix: a clinicopathological and molecular analysis of 59 cases with special emphasis on histogenesis and potential therapeutic targets.
Yao Y; Wang Y; Ye L; Lu B; Lu W
Histopathology; 2024 Jan; 84(2):315-324. PubMed ID: 37735961
[TBL] [Abstract] [Full Text] [Related]
2. Splicing factor SRSF3 promotes the progression of cervical cancer through regulating ddx5.
Che Y; Bai M; Lu K; Fu L
Mol Carcinog; 2023 Feb; 62(2):210-223. PubMed ID: 36282044
[TBL] [Abstract] [Full Text] [Related]
3. Neoadjuvant radiotherapy and brachytherapy in endometrial cancer with gross cervical involvement: a CHIRENDO research group study.
Brodeur MN; Samouëlian V; Dabi Y; Cormier B; Beauchemin MC; Barkati M
Int J Gynecol Cancer; 2021 Jan; 31(1):78-84. PubMed ID: 33127863
[TBL] [Abstract] [Full Text] [Related]
4. Proteomic identification of potential biomarkers for cervical squamous cell carcinoma and human papillomavirus infection.
Qing S; Tulake W; Ru M; Li X; Yuemaier R; Lidifu D; Rouzibilali A; Hasimu A; Yang Y; Rouziahong R; Upur H; Abudula A
Tumour Biol; 2017 Apr; 39(4):1010428317697547. PubMed ID: 28443473
[TBL] [Abstract] [Full Text] [Related]
5. Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing.
Jiang FZ; He YY; Wang HH; Zhang HL; Zhang J; Yan XF; Wang XJ; Che Q; Ke JQ; Chen Z; Tong H; Zhang YL; Wang FY; Li YR; Wan XP
Oncotarget; 2015 Dec; 6(42):44660-74. PubMed ID: 26587974
[TBL] [Abstract] [Full Text] [Related]
6. The expression of RNA helicase ddx5 is transcriptionally upregulated by calcitriol through a vitamin D response element in the proximal promoter in SiHa cervical cells.
González-Duarte RJ; Cázares-Ordoñez V; Díaz L; Ortíz V; Larrea F; Avila E
Mol Cell Biochem; 2015 Dec; 410(1-2):65-73. PubMed ID: 26314252
[TBL] [Abstract] [Full Text] [Related]
7. Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping.
Ge S; Gong B; Cai X; Yang X; Gan X; Tong X; Li H; Zhu M; Yang F; Zhou H; Hong G
Cancer Med; 2012 Aug; 1(1):59-67. PubMed ID: 23342254
[TBL] [Abstract] [Full Text] [Related]
8. Cell-mediated immune response to human papillomavirus 16 E7 peptide pools in patients with cervical neoplasia.
Lee YS; Lee CW; Song MJ; Ho EM; Kim CJ; Park TC; Kim TG; Park JS
Acta Obstet Gynecol Scand; 2011 Dec; 90(12):1350-6. PubMed ID: 21916856
[TBL] [Abstract] [Full Text] [Related]
9. Evolution of treatment of high-risk metastatic gestational trophoblastic tumors: Ain Shams University experience.
El-Lamie IK; El Sayed HM; Badawie AG; Bayomi WA; El-Ghazaly HA; Khalaf-Allah AE; El-Mahallawy MN; El-Lamie KI
Int J Gynecol Cancer; 2006; 16(2):866-74. PubMed ID: 16681775
[TBL] [Abstract] [Full Text] [Related]
10. Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India.
Sankaranarayanan R; Nene BM; Dinshaw K; Rajkumar R; Shastri S; Wesley R; Basu P; Sharma R; Thara S; Budukh A; Parkin DM
Salud Publica Mex; 2003; 45 Suppl 3():S399-407. PubMed ID: 14746033
[TBL] [Abstract] [Full Text] [Related]
11. [Use of hysteroscopy, ultrasonography and selected hormonal tests for diagnosis of hyperplastic endometrial changes].
Bedner R
Ann Acad Med Stetin; 2001; 47():89-105. PubMed ID: 12514904
[TBL] [Abstract] [Full Text] [Related]
12. [Evaluation of endometrial changes in women with cyclical mastalgia].
Wypych K; Spiewankiewicz B; Sawicki W
Ginekol Pol; 1995 Aug; 66(8):451-6. PubMed ID: 8675069
[TBL] [Abstract] [Full Text] [Related]
13. 1.5-5 years of uninterrupted cis-diamminedichloroplatinum II chemotherapy for metastatic cervical cancer.
Piver MS; Lele SB; Patsner B; McPhee ME
Gynecol Oncol; 1987 May; 27(1):24-33. PubMed ID: 3570047
[TBL] [Abstract] [Full Text] [Related]
